Literature DB >> 18941186

Heterospecific CD4 help to rescue CD8 T cell killers.

Marie-Ghislaine de Goër de Herve1, Anne Cariou, Federico Simonetta, Yassine Taoufik.   

Abstract

Help from CD4 T cells may be required for optimal generation and maintenance of memory CD8 T cells and also for optimal Ag reactivation. We examined whether the helper cell and the CD8 killer cell need to have the same Ag specificity for help to be effective during interactions of memory T cells with mature APC. This is important because virus and tumor Ag-specific CD4 T cell responses are selectively impaired in several chronic viral infections and malignancies. We performed studies in vitro and in vivo and found that functional memory CD4 T cells generated from a distinct antigenic source (heterospecific helpers) could provide direct and effective help to memory CD8 T cells. Functional heterospecific memory CD4 T cells could also rescue secondary CD8 T cell responses in an experimental tumor model in which homospecific CD4 help was impaired. This could provide a rationale for immunotherapy strategies designed to bypass impaired homospecific help.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18941186     DOI: 10.4049/jimmunol.181.9.5974

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection.

Authors:  Sojung Kim; Adam Zuiani; Javier A Carrero; Ted H Hansen
Journal:  Vaccine       Date:  2012-01-26       Impact factor: 3.641

Review 2.  Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy.

Authors:  Akshata Udyavar; Terrence L Geiger
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-08-01       Impact factor: 4.291

3.  Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses.

Authors:  Takumi Kumai; Sujin Lee; Hyun-Il Cho; Hussein Sultan; Hiroya Kobayashi; Yasuaki Harabuchi; Esteban Celis
Journal:  Cancer Immunol Res       Date:  2016-12-09       Impact factor: 11.151

4.  CD4+ T Cell Help Selectively Enhances High-Avidity Tumor Antigen-Specific CD8+ T Cells.

Authors:  Ziqiang Zhu; Steven M Cuss; Vinod Singh; Devikala Gurusamy; Jennifer L Shoe; Robert Leighty; Vincenzo Bronte; Arthur A Hurwitz
Journal:  J Immunol       Date:  2015-08-28       Impact factor: 5.422

5.  Identification of Melanoma-reactive CD4+ T-Cell Subsets From Human Melanoma Draining Lymph Nodes.

Authors:  Mei Zhang; Hallie Graor; Lu Yan; Julian Kim
Journal:  J Immunother       Date:  2016-01       Impact factor: 4.456

6.  FoxP3⁺ regulatory CD4 T cells control the generation of functional CD8 memory.

Authors:  M G de Goër de Herve; S Jaafoura; M Vallée; Y Taoufik
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

7.  CD4+ T cell effects on CD8+ T cell location defined using bioluminescence.

Authors:  Mitra Azadniv; William J Bowers; David J Topham; Ian N Crispe
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

8.  Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy.

Authors:  Jacques Gasnault; Dominique Costagliola; Houria Hendel-Chavez; Anne Dulioust; Sophie Pakianather; Anne-Aurélie Mazet; Marie-Ghislaine de Goer de Herve; Rémi Lancar; Anne-Sophie Lascaux; Lydie Porte; Jean-François Delfraissy; Yassine Taoufik
Journal:  PLoS One       Date:  2011-06-30       Impact factor: 3.240

Review 9.  B cells and progressive multifocal leukoencephalopathy: search for the missing link.

Authors:  Deniz Durali; Marie-Ghislaine de Goër de Herve; Jacques Gasnault; Yassine Taoufik
Journal:  Front Immunol       Date:  2015-05-19       Impact factor: 7.561

10.  CD154 and IL-2 signaling of CD4+ T cells play a critical role in multiple phases of CD8+ CTL responses following adenovirus vaccination.

Authors:  Channakeshava Sokke Umeshappa; Roopa Hebbandi Nanjundappa; Yufeng Xie; Andrew Freywald; Yulin Deng; Hong Ma; Jim Xiang
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.